Nucleoside Metabolic Inhibitor
DBCAT003348Therapeutic category
A DrugBank category of 12 drugs. 12 of them are approved.
What you can answer from here — as of October 25, 2017
Which targets do Nucleoside Metabolic Inhibitor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account